ISO 25539-4:2021

Cardiovascular implants — Endovascular devices — Part 4: Application of ISO 17327-1 for coated endovascular devices

Cardiovascular implants — Endovascular devices — Part 4: Application of ISO 17327-1 for coated endovascular devices

Digital Document2021 edition2021Purchase Options

Referenced standards

ISO 12417-1:2015ISO 17327-1:2018ISO 25539-1:2017ISO 25539-2:2020ISO 25539-3:2011ISO/TS 17137:2021
Unit Price
USD50.70Save 22%
USD 65.00

PREVIEW

ISO 25539-4:2021

Cardiovascular implants — Endovascular devices — Part 4: Application of ISO 17327-1 for coated endovascular devices

Cardiovascular implants — Endovascular devices — Part 4: Application of ISO 17327-1 for coated endovascular devices

This document specifies the appropriate application of ISO?17327-1:2018 to coated endovascular prostheses, vascular stents, and vena cava filters. This document is intended to be used as a supplement to ISO?25539-1, ISO?25539-2, ISO?25539-3, ISO?12417-1 and ISO/TS?17137.

The following coatings are within the scope of ISO?17327-1 and addressed in this document for endovascular devices: drug coatings (eluting and non-eluting), non-drug coatings (absorbable and non-absorbable), and chemistry-related surface modifications (oxide, such as TiO2, and non-oxide, such as amorphous silicon carbide and diamond-like carbon).

This document is not applicable to coated delivery systems or coated ancillary devices (e.g. guidewires), as these coatings are not within the scope of ISO?17327-1, which is specifically directed to implant coatings.

This document is not applicable to coverings of endovascular devices; however, if the covering of a device is coated, it is within the scope of this document.

This document does not address the requirements for, and the evaluation of, viable tissues and non-viable biologic materials used as implant coatings.

Edition2021
Standard Part No4
Published Date2021
Published ByInternational Standardization Organisation
Page Count11